Combination treatment approved for overactive bladder

被引：0

|

作者：

不详

机构：

来源：

NURSE PRACTITIONER | 2018年 / 43卷 / 09期

关键词：

D O I：

暂无

中图分类号：

R47 [护理学];

学科分类号：

1011 ;

摘要：

引用

收藏

页码：56 / 56

页数：1

相关论文

共 50 条

[1] Mirabegron approved for overactive bladder
Traynor, Kate
AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY, 2012, 69 (15) : 1270 - 1270
[2] Toviaz approved for overactive bladder
Traynor, Kate
AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY, 2008, 65 (23) : 2184 - 2184
[3] PFIZER Muscarinic receptor antagonist approved for the treatment of overactive bladder
不详
FORMULARY, 2008, 43 (12) : 434 - 435
[4] Combination Pharmacotherapy for Treatment of Overactive Bladder (OAB)
El-Zawahry, Ahmed
CURRENT UROLOGY REPORTS, 2019, 20 (06)
[5] Combination Pharmacotherapy for Treatment of Overactive Bladder (OAB)
Ahmed El-Zawahry
Current Urology Reports, 2019, 20
[6] Fluorimetric study on a novel FDA-approved combination used for the treatment of overactive bladder syndrome in different matrices
Nour, Israa M.
Mohamed, Ahmed R.
Hasan, Mohamed A.
Badrawy, Mohamed
SPECTROCHIMICA ACTA PART A-MOLECULAR AND BIOMOLECULAR SPECTROSCOPY, 2024, 307
[7] Treatment of overactive bladder: Expanding on conservative treatment by establishing combination therapy
Bauer S.
Lusuardi L.
Journal für Urologie und Urogynäkologie/Österreich, 2019, 26 (3): : 92 - 97
[8] Treatment of overactive bladder
Chapple, C.
UROLOGE, 2007, 46 (04): : 422 - +
[9] Treatment of the overactive bladder
Wagenlehner, FME
DEUTSCHE MEDIZINISCHE WOCHENSCHRIFT, 2005, 130 (03) : 118 - 118
[10] Treatment of overactive bladder
Peschers U.
Der Gynäkologe, 2017, 50 (3): : 184 - 188

← 1 2 3 4 5 →